BP1210

Ritonavir

British Pharmacopoeia (BP) Reference Standard

• Synonim(y): 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
• Wzór empiryczny (zapis Hilla): C₃₇H₄₈N₆O₅S₂
• Numer CAS: 155213-67-5
• Masa cząsteczkowa: 720.94
• Kod UNSPSC: 41116107
• NACRES: NA.24

Właściwości

• klasa czystości: pharmaceutical primary standard
• Poziom jakości: 100
• agency: BP
• rodzina API: ritonavir
• Postać: solid
• okres trwałości: limited shelf life, expiry date on the label
• opakowanie: pkg of 100 mg
• producent / nazwa handlowa: BP
• warunki przechowywania: dry at room temperature
• kolor: off-white
• mp: 122-126 °C
• rozpuszczalność: ethanol: soluble; isopropanol: soluble; methanol: soluble
• gęstość: 1.239 g/cm³ at 20 °C
• Zastosowanie: pharmaceutical; pharmaceutical small molecule
• format: neat
• Warunki transportu: ambient
• temp. przechowywania: 2-8°C
• InChI: 1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1
• Klucz InChI: NCDNCNXCDXHOMX-XGKFQTDJSA-N

Opis

Opis ogólny

Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Zastosowanie

Ritonavir BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Ritonavir Oral Solution

Ritonavir Tablets

Opakowanie

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Inne uwagi

Sales restrictions may apply.

Informacja o środkach bezpieczeństwa

• Piktogramy: GHS07
• Hasło ostrzegawcze: Warning
• Zwroty wskazujące rodzaj zagrożenia: H302 + H312 + H332
• Zwroty wskazujące środki ostrożności: P280 - P301 + P312 + P330 - P302 + P352 + P312 - P304 + P340 + P312
• Klasyfikacja zagrożeń: Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
• Kod klasy składowania: 11 - Combustible Solids
• Klasa zagrożenia wodnego (WGK): WGK 3
• Temperatura zapłonu (°F): Not applicable
• Temperatura zapłonu (°C): Not applicable